CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GSK plc

GSK
$99.27B
Large Cap
NYSEPharmaceutical PreparationsPharmaceutical🇺🇸EuropeLONDON65.0K employees

GSK plc (an abbreviation of its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.

Website

Drugs in Pipeline

554

Phase 3 Programs

300

Upcoming Catalysts

20

Next Catalyst

Apr 30, 2026

8w

Market Overview

Stock performance and key metrics

GSK News
Catalyst Timeline

20 upcoming, 0 past

Drug Pipeline

Daprodustat small

Phase 3

Anaemia

enoxaparin

Phase 3

Thromboembolism

Chemotherapy

Phase 3

Melanoma

GSK 573719 +GW642444 125/25

Phase 3

Pulmonary Disease, Chronic Obstructive

GSK1562902A

Phase 3

Influenza

Priorix

Phase 3

Measles; Mumps; Rubella

GSK3511294 (Depemokimab)

Phase 3

Asthma

fondaparinux - UFH not indicated

Phase 3

Thromboembolism

Sumatriptan 25 mg

Phase 3

Migraine Disorders

Daratumumab

Phase 3

Multiple Myeloma

fluticasone propionate/salmeterol 250/50 DISKUS combination product

Phase 3

Pulmonary Disease, Chronic Obstructive

GW572016 (Lapatinib)

Phase 3

Neoplasms, Breast

Havrix™

Phase 3

Hepatitis A

0.254% w/w sodium fluoride and 5% KNO3

Phase 3

Tooth Erosion

fluticasone propionate inhalation solution

Phase 3

Asthma

Combined diphtheria, tetanus, acellular pertussis vaccine

Phase 3

Diphtheria

Linerixibat

Phase 3

Pruritus

PCV20

Phase 3

Respiratory Syncytial Virus Infections

GSK Biologicals' candidate Plasmodium falciparum malaria vaccine (257049)

Phase 3

Malaria

LAMICTAL extended-release

Phase 3

Epilepsy

GSK573719/GW642444 Inhalation Powder

Phase 3

Pulmonary Disease, Chronic Obstructive

Twinrix ™ Paediatric

Phase 3

Infections, Papillomavirus

darapladib

Phase 3

Retinopathy, Diabetic

GSK Biologicals HPV 16/18 vaccine 580299 (CervarixTM)

Phase 3

Infections, Papillomavirus

Bortezomib

Phase 3

Multiple Myeloma

MenitorixTM

Phase 3

Neisseria Meningitidis

Mepolizumab 300 mg

Phase 3

Hypereosinophilic Syndrome

Boostrix

Phase 3

Tetanus

Retigabine IR

Phase 3

Epilepsy

Insulin Glargine and Insulin Lispro

Phase 3

Diabetes Mellitus, Type 2

Herpes simplex candidate vaccine- adjuvanted GSK 208141

Phase 3

Prophylaxis for Herpes Simplex

Fondaparinux sodium

Phase 3

Embolism, Pulmonary

Belimumab 10 mg/kg plus standard therapy

Phase 3

Lupus Nephritis

Danazol

Phase 3

Primary Myelofibrosis

GSK Biologicals' HPV vaccine 580299

Phase 3

Infections, Papillomavirus

Influsplit Tetra™ vaccine produced by investigational process (IP)

Phase 3

Influenza

2-dose oral live attenuated G1P[8] human rotavirus vaccine

Phase 3

Infections, Rotavirus

Ezogabine: USAN Retigabine (International Nonproprietary Name)

Phase 3

Epilepsy

Mepolizumab 100mg

Phase 3

Asthma

DTPw-HBV/Hib Kft vaccine GSK323527A

Phase 3

Hepatitis B

Rosiglitazone

Phase 3

Diabetes Mellitus, Type 2

GSK573719/GW642444 62.5/25

Phase 3

Pulmonary Disease, Chronic Obstructive

Intravenous (IV) zanamivir

Phase 3

Influenza, Human

LEXIVA (GW433908)

Phase 3

HIV Infection

mometasone furoate

Phase 3

Rhinitis, Allergic, Perennial

Dutasteride 0.5 mg

Phase 3

Alopecia

Influenza vaccine GSK2321138A

Phase 3

Influenza

Pneumococcal conjugate vaccine GSK1024850A.

Phase 3

Infections, Streptococcal

mRNA-1273

Phase 3

Herpes Zoster

HSV vaccine or SB208141, GSK Biologicals' glycoprotein D (gD)-Alum/3-deacylated form of Monophosphoryl Lipid A (MPL) candidate genital herpes vaccine

Phase 3

Herpes Simplex Infection

PoliorixTM

Phase 3

Poliomyelitis

Fluticasone Furoate/GW642444

Phase 3

Asthma

Nitrofurantoin

Phase 3

Urinary Tract Infections

GSK573719/GW642444 125/25mcg

Phase 3

Pulmonary Disease, Chronic Obstructive

Ropinirole

Phase 3

Restless Legs Syndrome

Itraconazole 100mg capsules

Phase 3

Onychomycosis

alitretinoin

Phase 3

Eczema

pazopanib

Phase 3

Glioma

CTGel/ BPO Wash

Phase 3

Acne Vulgaris

CAPEOX

Phase 3

Colonic Neoplasms

Momelotinib

Phase 3

Primary Myelofibrosis

GW815SF HFA MDI

Phase 3

Bronchial Asthma

fluticasone furoate/vilanterol

Phase 3

Pulmonary Disease, Chronic Obstructive

Vilanterol

Phase 3

Asthma

Belimumab 1 mg/kg

Phase 3

Systemic Lupus Erythematosus

Liarozole

Phase 3

Ichthyosis, Lamellar

Sodium Monofluorophosphate

Phase 3

Dentine Hypersensitivity

Meningococcal vaccine GSK134612

Phase 3

Infections, Meningococcal

NC-503 (Anti-amyloidotic (AA) Agent)

Phase 3

Secondary (AA) Amyloidosis

HBV-MPL vaccine 208129

Phase 3

Hepatitis B

Azathioprine

Phase 3

Vasculitis

Belimumab 200 mg SC

Phase 3

Systemic Lupus Erythematosus

clindamycin / benzoyl peroxide gel

Phase 3

Acne Vulgaris

Umeclidinium

Phase 3

Hyperhidrosis

Paracetamol 1000 mg SR tablets

Phase 3

Pain

U0267

Phase 3

Psoriasis

Calcipotriene Foam

Phase 3

Psoriasis

GlaxoSmithKline (GSK) Biologicals' candidate Plasmodium falciparum malaria vaccine 257049

Phase 3

Malaria

sodium fluoride

Phase 3

Enamel Erosion

BLU-5937

Phase 3

Cough

Tazarotene foam

Phase 3

Acne Vulgaris

CT Gel

Phase 3

Acne Vulgaris

GW685698X

Phase 3

Asthma

Belimumab

Phase 3

Systemic Lupus Erythematosus

Retpamulin Ointment, 1%

Phase 3

Skin Infections, Bacterial

Ruxolitinib

Phase 3

Primary Myelofibrosis

Best Available Therapy (BAT)

Phase 3

Primary Myelofibrosis (PMF)

Botulinum toxin A (GSK1358820)

Phase 3

Spasticity, Post-Stroke

Haemophilus influenzae type b and meningococcal serogroup C (vaccine)

Phase 3

Haemophilus Influenzae Type b

Dutasteride

Phase 3

Alopecia

U0267 Foam

Phase 3

Psoriasis

albuterol/salbutamol

Phase 3

Asthma

Combination Tablet of Treximet (sumatriptan/naproxen sodium)

Phase 3

Migraine Disorders

SB-275833 ointment, 1%

Phase 3

Impetigo

Rotarix (primary vaccination study)

Phase 3

Infections, Rotavirus

Fluticasone Furoate (FF)/GW642444 Inhalation Powder

Phase 3

Pulmonary Disease, Chronic Obstructive

Tritanrix™- HepB

Phase 3

Infections, Meningococcal

Herpes Zoster vaccine GSK 1437173A

Phase 3

Herpes Zoster

denosumab

Phase 3

Osteoporosis, Postmenopausal

Niraparib

Phase 3

Ovarian Neoplasms

AAAA

Phase 3

Chronic Hepatitis B

lisinopril

Phase 3

Hypertension

Lamivudine plus Polyethylene glyco-interferon alfa-2b

Phase 3

Chronic Hepatitis B

Sodium Fluoride Toothpaste

Phase 3

Caries

Infanrix+Hib™

Phase 3

Acellular Pertussis

GSK3511294

Phase 3

Asthma

sumatriptan succinate/naproxen sodium

Phase 3

Migraine

Sumatriptan and Naproxen Sodium

Phase 3

Migraine Disorders

ropinirole controlled-release (REQUIP CR) for RLS

Phase 3

Parkinson's Disease

Cervarix TM

Phase 3

Infections, Papillomavirus

fosamprenavir

Phase 3

HIV Infections

montelukast (5mg QD)

Phase 3

Asthma

GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108)

Phase 3

Haemophilus Influenzae Type b

ropinirole Extended Release (XR)

Phase 3

Restless Legs Syndrome

HPV-16/18 L1/AS04

Phase 3

Infections, Papillomavirus

Pneumococcal vaccine GSK1024850A

Phase 3

Infections, Streptococcal

Otelixizumab

Phase 3

Diabetes Mellitus, Type 1

insulin glargine

Phase 3

Diabetes Mellitus, Type 2

Quadrivalent influenza GSK2282512A vaccine

Phase 3

Influenza

Experimental Denture Adhesive

Phase 3

Denture Retention

lamotrigine extended-release

Phase 3

Epilepsy

Fluticasone Furoate 100mcg / GW642444 (vilanterol) 25mcg

Phase 3

Pulmonary Disease, Chronic Obstructive

GSK1120212

Phase 3

Cancer

H5N1 adjuvanted split virus vaccine (A/Vietnam/1194/2004 strain)

Phase 3

Influenza

Depemokimab

Phase 3

Pulmonary Disease, Chronic Obstructive

Cervarix

Phase 3

Human Papillomavirus (HPV) Infection

Pneumococcal (vaccine)

Phase 3

Acellular Pertussis

GSK investigational vaccine GSK2340272A

Phase 3

Influenza

SB213503 lot 1

Phase 3

Tetanus

GSK1325760A

Phase 3

Pulmonary Arterial Hypertension

Thiomersal free trivalent influenza split vaccine 2003/2004

Phase 3

Influenza

Casopitant (GW679769) oral tablets

Phase 3

Vomiting

Fluticasone furoate

Phase 3

Rhinitis

Netivudine

Phase 3

HIV Infections

Engerix™-B

Phase 3

Hepatitis B

GW685698X Aqueous Nasal Spray

Phase 3

Rhinitis, Allergic, Seasonal

Efimosfermin alfa

Phase 3

Non-alcoholic Fatty Liver Disease

Abacavir sulfate

Phase 3

HIV Infections

FSC

Phase 3

Pulmonary Disease, Chronic Obstructive

Botulinum Toxin Type A

Phase 3

Glabellar Lines

Lamivudine

Phase 3

HIV Infections

Pentamidine isethionate

Phase 3

Pneumonia, Pneumocystis Carinii

Fluviral®

Phase 3

Influenza

HRV Liquid

Phase 3

Rotavirus

Lamivudine/Zidovudine

Phase 3

HIV Infections

Zidovudine

Phase 3

HIV Infections

Atovaquone

Phase 3

Pneumonia, Pneumocystis Carinii

Dutasteride 0.5mg capsule

Phase 3

Benign Prostatic Hyperplasia

albiglutide

Phase 3

Diabetes Mellitus, Type 2

Amprenavir

Phase 3

HIV Infections

Gepotidacin

Phase 3

Infections, Bacterial

Lovaza (omega-3-acid ethyl esters) [formerly known as Omacor] plus atorvastatin

Phase 3

Hypertriglyceridemia

Indinavir sulfate

Phase 3

HIV Infections

GSK1278863

Phase 3

Anaemia

Levocetirizine

Phase 3

Rhinitis

Ropinirole XL (formerly CR)

Phase 3

Parkinson Disease

GSK1358820

Phase 3

Urinary Bladder, Overactive

FF/GW642444 Inhalation Powder

Phase 3

Pulmonary Disease, Chronic Obstructive

GSK investigational vaccine GSK1557482A

Phase 3

Influenza

Fluticasone furoate 50mcg

Phase 3

Asthma

Casopitant

Phase 3

Nausea and Vomiting, Chemotherapy-Induced

fondaparinux

Phase 3

Fibrillation, Atrial

Cervarix™ (HPV-16/18 L1 VLP AS04)

Phase 3

Infections, Papillomavirus

ropinirole PR/XR

Phase 3

Parkinson Disease

Standard therapy (Including Immunosuppressants)

Phase 3

Systemic Lupus Erythematosus

GSK Biologicals' combined diphtheria, tetanus, acellular pertussis vaccine

Phase 3

Diphtheria

Fluarix/Influsplit SSW 2012-2013

Phase 3

Influenza

Rotarix

Phase 3

Infections, Rotavirus

human papillomavirus 16/18 L1 virus-like particle/AS04 vaccine

Phase 3

Cervical Cancer

Subjects received 3 doses of GSK Biologicals' HPV vaccine (580299) (Cervarix™)

Phase 3

Infections, Papillomavirus

lamotrigine

Phase 3

Schizophrenia

paroxetine

Phase 3

Social Anxiety Disorder

Retosiban

Phase 3

Obstetric Labour, Premature

MMRV

Phase 3

Rubella

1mg Glimepiride/10mg Atorvastatin FDC

Phase 3

Diabetes Mellitus, Type 2

Twinrix™ adult

Phase 3

Hepatitis B

FF/VI via ELLIPTA DPI

Phase 3

Asthma

GW642444 Inhalation Powder

Phase 3

Pulmonary Disease, Chronic Obstructive

Synflorix

Phase 3

Infections, Streptococcal

RSVPreF3 OA vaccine

Phase 3

Respiratory Syncytial Virus Infections

GSK573719

Phase 3

Pulmonary Disease, Chronic Obstructive

PCV-free liquid formulation of GSK's oral live attenuated HRV vaccine

Phase 3

Infections, Rotavirus

Fluarix

Phase 3

Influenza

Boostrix™

Phase 3

Diphtheria

1% diclofenac sodium plus 3% menthol

Phase 3

Pain

GSK580299 (Cervarix)

Phase 3

Infections, Papillomavirus

Meningococcal vaccine GSK 134612

Phase 3

Meningococcal Infection

mepolizumab

Phase 3

Hypereosinophilia

Umeclidinium/Vilanterol 62.5/25 mcg

Phase 3

Pulmonary Disease, Chronic Obstructive

FF

Phase 3

Rhinitis, Allergic, Perennial

GSK investigational FluNG vaccine GSK2186877A, aged lot

Phase 3

Influenza

DTPw-HBV/Hib-MenAC conjugate vaccine

Phase 3

Diphtheria

Paclitaxel

Phase 3

Carcinoma

Pediarix

Phase 3

Poliomyelitis

Measles, Mumps, Rubella and Chickenpox (live vaccine)

Phase 3

Measles

GSK Biologicals' liquid human rotavirus vaccine 444563

Phase 3

Infections, Rotavirus

stannous fluoride

Phase 3

Dentin Sensitivity

PriorixTetra™

Phase 3

Rubella

Mepolizumab IV

Phase 3

Asthma

FF/UMEC/VI

Phase 3

Asthma

HRV PCV-free liquid vaccine

Phase 3

Infections, Rotavirus

GSK investigational vaccine 2186877A

Phase 3

Influenza

Denosumab 70 mg/mL

Phase 3

Fractures, Bone

GW815SF Salmeterol/Fluticasone propionate(HFA MDI)

Phase 3

Bronchial Asthma

Infanrix Hexa

Phase 3

Acellular Pertussis

Herpes Zoster Vaccine GSK1437173A

Phase 3

Herpes Zoster

Dostarlimab

Phase 3

Neoplasms, Rectal

Malaria Vaccine 257049

Phase 3

Malaria

GSK580299, GSK Biological's HPV vaccine

Phase 3

Infections, Papillomavirus

HZ/su vaccine GSK1437173A

Phase 3

Herpes Zoster

BW430C (lamotrigine)

Phase 3

Bipolar Disorder

Albiglutide 30 mg weekly

Phase 3

Diabetes Mellitus, Type 2

RSVPreF3 OA investigational vaccine

Phase 3

Respiratory Syncytial Virus Infections

Priorix®

Phase 3

Rubella

Daprodustat

Phase 3

Anaemia

HZ/su

Phase 3

Herpes Zoster

nicotine

Phase 3

Smoking Cessation

Mencevax™ACWY

Phase 3

Infections, Meningococcal

Adacel

Phase 3

Acellular Pertussis

Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (A/Indonesia)

Phase 3

Influenza

Meningitec™

Phase 3

Infections, Meningococcal

Investigational varicella vaccine

Phase 3

Chickenpox

Mencevax ACWY

Phase 3

Infections, Meningococcal

Prophylaxis: Diphtheria, tetanus and pertussis

Phase 3

Acellular Pertussis

Prednisolone

Phase 3

Arthritis, Rheumatoid

rosiglitazone/metformin

Phase 3

Diabetes Mellitus, Type 2

SOC

Phase 3

Asthma

Abciximab

Phase 3

Infarction, Myocardial

GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations)

Phase 3

Influenza

GSK523338

Phase 3

Diabetes Mellitus, Type 2

Rosiglitazone 4 mg

Phase 3

Type 2 Diabetes Mellitus

GSK1605786A

Phase 3

Crohn's Disease

Fluticasone Furoate 100mcg/Vilanterol 25mcg

Phase 3

Pulmonary Disease, Chronic Obstructive

GSK Biologicals Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A)

Phase 3

Herpes Zoster

Ropinirole prolonged release

Phase 3

Parkinson Disease

Pomalidomide

Phase 3

Multiple Myeloma

Belantamab mafodotin

Phase 3

Multiple Myeloma

Fluticasone propionate

Phase 3

Asthma

Lapatinib

Phase 3

Metastatic Breast Cancer

Influenza vaccine GSK2340272A

Phase 3

Influenza

Fluticasone Furoate/GW642444 Inhalation Powder 100/25mcg

Phase 3

Pulmonary Disease, Chronic Obstructive

10 valent pneumococcal conjugate vaccine

Phase 3

Infections, Rotavirus

Infanrix-IPV+Hib™

Phase 3

Acellular Pertussis

Oral Casopitant (GW679769)

Phase 3

Nausea and Vomiting, Chemotherapy-Induced

UMEC/VI Inhalation Powder 62.5/25 mcg via NDPI

Phase 3

Pulmonary Disease, Chronic Obstructive

Tritanrix-HepB/Meningitec conjugate vaccine

Phase 3

Diphtheria

Avandia

Phase 3

Insulin Resistance

Quadrivalent seasonal influenza vaccine(Flu D-QIV) GSK2321138A

Phase 3

Influenza

Lamictal

Phase 3

Epilepsy

Tenofovir disoproxil fumarate (TDF) tablets

Phase 3

Hepatitis B

Rosiglitazone Extended Release 2mg

Phase 3

Alzheimer's Disease

FluLaval™ Quadrivalent

Phase 3

Influenza

Rosiglitazone (BRL49653C)

Phase 3

Diabetes Mellitus, Type 2

diphtheria, tetanus, pertussis & Hib vaccine

Phase 3

Tetanus

Amoxicillin-Potassium Clavulanate Combination

Phase 3

Sinusitis, Acute

Fluoride

Phase 3

Dental Caries

62.5/25mcg

Phase 3

Pulmonary Disease, Chronic Obstructive

Losmapimod 7.5 mg twice daily

Phase 3

Acute Coronary Syndrome

Combined Hepatitis A and B vaccine

Phase 3

Hepatitis B

GSK Biologicals' Meningococcal vaccine GSK134612 (Nimenrix)

Phase 3

Infections, Meningococcal

Haemophilus influenzae type b- and meningococcal (vaccine)

Phase 3

Haemophilus Influenzae Type b

FLU-QIV

Phase 3

Respiratory Syncytial Virus Infections

glyburide

Phase 3

Diabetes Mellitus, Type 2

Sulfonylurea

Phase 3

Diabetes Mellitus

Salbutamol HFA-134a

Phase 3

Asthma

alosetron

Phase 3

Irritable Colon

Cervarix™

Phase 3

Infections, Papillomavirus

GW406381

Phase 3

Arthritis, Rheumatoid

HBV-MPL vaccine

Phase 3

Hepatitis B

DTPa-HBV-IPV/Hib

Phase 3

Haemophilus Influenzae Type b

Extended-release Bupropion Hydrochloride

Phase 3

Major Depressive Disorder (MDD)

DTPa-HBV-IPV/Hib (Infanrix hexa™)

Phase 3

Hepatitis B

Umeclidinium/vilanterol

Phase 3

Pulmonary Disease, Chronic Obstructive

Lyophilized mepolizumab

Phase 3

Asthma

GSK573719/GW642444 125/25

Phase 3

Pulmonary Disease, Chronic Obstructive

Umeclidinium bromide 62.5mcg

Phase 3

Pulmonary Disease, Chronic Obstructive

Live attenuated human rotavirus vaccine

Phase 3

Rotavirus Gastroenteritis

paracetamol + caffeine

Phase 3

Common Cold

HZ/su vaccine

Phase 3

Respiratory Syncytial Viruses

VI

Phase 3

Pulmonary Disease, Chronic Obstructive

Tiotropium

Phase 3

Pulmonary Disease, Chronic Obstructive

GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine

Phase 3

Haemophilus Influenzae Type b

GSK Bio's influenza vaccine GSK2186877A

Phase 3

Influenza

FF/VI

Phase 3

Pulmonary Disease, Chronic Obstructive

Depemokimab (GSK3511294)

Phase 3

Nasal Polyps

Fluticasone Furoate/ Vilanterol 200/25 mcg

Phase 3

Asthma

Pneumococcal conjugate vaccine GSK1024850A

Phase 3

Infections, Streptococcal

Mencevax™ ACWY

Phase 3

Infections, Meningococcal

fluticasone furoate + vilanterol

Phase 3

Asthma

Influsplit™ Tetra (Fluarix™ Tetra)

Phase 3

Influenza

Fluarix Quadrivalent

Phase 3

Influenza

Umeclidinium bromide

Phase 3

Pulmonary Disease, Chronic Obstructive

Fluticasone furoate/Vilanterol Inhalation Powder

Phase 3

Asthma

Havrix®

Phase 3

Hepatitis A

323U66 (Bupropion Hydrochloride Sustained Release)

Phase 3

Depressive Disorder

Engerix™-B (thiomersal-free) 20µg

Phase 3

Hepatitis B

valaciclovir HCl granules

Phase 3

Varicella

Bexsero (GSK Biologicals' Meningococcal group-B vaccine/ rMenB+OMV NZ)

Phase 3

Infections, Meningococcal

Tritanrix-HepB/Hib-MenAC

Phase 3

Whole Cell Pertussis

HBV-MPL 208129

Phase 3

Hepatitis B

GSK2269557 DPI

Phase 2

Pulmonary Disease, Chronic Obstructive

Adjuvanted Hepatitis B surface antigen (HBsAg) candidate vaccine GSK2231392A.

Phase 2

Hepatitis B

SB-681323 Intravenous 3mg

Phase 2

Lung Injury, Acute

Metformin

Phase 2

Diabetes Mellitus, Type 2

RSV Vaccine (GSK3003891A) formulation 1

Phase 2

Respiratory Syncytial Virus Infections

RTS,S/AS01E

Phase 2

Malaria

intravenous ondansetron

Phase 2

Postoperative Nausea and Vomiting

GSK5784283

Phase 2

Asthma

SB-485232

Phase 2

Melanoma

Investigational MMRV(H)NS vaccine

Phase 2

Measles; Mumps; Rubella; Chickenpox

16448

Phase 2

Premature Ejaculation

GSK239512

Phase 2

Schizophrenia

GSK Biologicals HIV Vaccine 732462

Phase 2

AIDS

1278863A

Phase 2

Kidney Disease

foretinib (formerly GSK1363089 or XL880)

Phase 2

Carcinoma, Renal Cell

GSK Biologicals' GSK2340274A (two different formulations)

Phase 2

Influenza

Tritanrix™ HB+Hib

Phase 2

Tuberculosis

GS856553

Phase 2

Pain, Neuropathic

GBS Trivalent Vaccine

Phase 2

Bacterial Infection Due to Streptococcus, Group B

GSK malaria vaccine 257049 Vaccine

Phase 2

Malaria

GW869682

Phase 2

Obesity

A/turkey H5N1 vaccine

Phase 2

Influenza

GSK364735

Phase 2

Infection, Human Immunodeficiency Virus

albiglutide (GSK716155)

Phase 2

Diabetes Mellitus, Type 2

GSK4527226

Phase 2

Alzheimer's Disease

Invasive nontyphoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) low dose

Phase 2

Salmonella Infections

Feladilimab

Phase 2

Multiple Myeloma

SB424323

Phase 2

Fibrillation, Atrial

GSK233705B

Phase 2

Pulmonary Disease, Chronic Obstructive

GSK835726 10mg

Phase 2

Rhinitis, Allergic, Seasonal

MenHibrix (Hib-MenCY-TT)

Phase 2

Neisseria Meningitidis

Aprepitant

Phase 2

Nausea and Vomiting

Varilrix (inactivated varicella vaccine)

Phase 2

Varicella

GW876008

Phase 2

Irritable Colon

Conjugated meningococcal ACWY-TT (vaccine)

Phase 2

Infections, Meningococcal

GSK256073 1mg

Phase 2

Diabetes Mellitus, Type 2

GSK2190915

Phase 2

Asthma

Ofatumumab

Phase 2

Lymphoma, Large-Cell, Diffuse

Cyclophosphamide

Phase 2

Lymphoma, Follicular

GW766944

Phase 2

Asthma

GSK2402968

Phase 2

Muscular Dystrophies

Priorix-Tetra (combined measles-mumps-rubella-varicella vaccine)

Phase 2

Measles

GlaxoSmithKline (GSK) Biologicals' investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (ChAd3-EBO-Z) (GSK3390107A)

Phase 2

Virus Diseases

10mg atorvastatin

Phase 2

Dyslipidaemias

Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab)

Phase 2

Lymphoma, Non-Hodgkin

Prevenar 13

Phase 2

Acellular Pertussis

GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049

Phase 2

Malaria

Cobolimab

Phase 2

Melanoma

Fluticasone propionate 100mcg

Phase 2

Asthma

GSK2269557

Phase 2

Pulmonary Disease, Chronic Obstructive

Otilimab

Phase 2

Severe Acute Respiratory Syndrome

Paracetamol hot drink

Phase 2

Common Cold

5% KNO3 / 0.2542% NaF dentifrice with 0.5% spherical silica

Phase 2

Oral Hygiene

Iodine I 131 Tositumomab

Phase 2

Non-Hodgkin's Lymphoma

Luspatercept

Phase 2

Primary Myelofibrosis

Sodium bicarbonate and sodium fluoride

Phase 2

Oral Hygiene

GSK2202083A vaccine

Phase 2

Tetanus

fluorouracil

Phase 2

Neoplasms, Breast

FLU-Q-PAN H7N9 Formulation 1

Phase 2

Influenza, Human

salmeterol 50mcg

Phase 2

Asthma

GSK2894512 1% Cream

Phase 2

Psoriasis

GSK2982772

Phase 2

Psoriasis

Pandemic influenza vaccine (GSK1562902A) (adjuvanted or not)

Phase 2

Influenza

GSK1521498

Phase 2

Obesity

F2C22C/DL001Z

Phase 2

Influenza, Human

Lapatinib and Capecitabine

Phase 2

Neoplasms, Gastrointestinal Tract

HBV-MPL vaccine (208129)

Phase 2

Hepatitis B

rhEPO

Phase 2

Anaemia

Chlorproguanil-dapsone-artesunate (CDA)

Phase 2

Malaria

Belrestotug

Phase 2

Neoplasms, Head and Neck

HIV vaccine 732461

Phase 2

AIDS

GSK2798745 solution

Phase 2

Oedema, Pulmonary

meningococcal ACWY (vaccine)

Phase 2

Infections, Meningococcal

SB-480848 40 mg

Phase 2

Atherosclerosis

Thiomersal-free FluAS25 adjuvanted vaccine (GSK576389A)

Phase 2

Influenza

GSK's candidate Mycobacterium tuberculosis vaccine 692342

Phase 2

Tuberculosis

GSK2036874A vaccine

Phase 2

Haemophilus Influenzae Type b

ropinirole controlled release (CR)-RLS

Phase 2

Restless Legs Syndrome

Infanrix hexa Vaccine

Phase 2

Acellular Pertussis

GW493838

Phase 2

Neuropathic Pain

Meningococcal vaccine 134612

Phase 2

Infections, Meningococcal

NTHi-10-AS01E

Phase 2

Respiratory Disorders

Menactra®

Phase 2

Infections, Meningococcal

GSK835726 (10mg)

Phase 2

Rhinitis, Allergic, Seasonal

GW810781

Phase 2

HIV Infections

PegIFN

Phase 2

Hepatitis B

Nirogacestat

Phase 2

Multiple Myeloma

GSK1292263

Phase 2

Diabetes Mellitus, Type 2

Albiglutide (GSK716155) or exenatide

Phase 2

Diabetes Mellitus, Type 2

GSK2894512 0.5% Cream

Phase 2

Dermatitis, Atopic

Nicotine lower dose

Phase 2

Smoking

FP

Phase 2

Rhinitis

Adjuvanted RSVPreF3 vaccine

Phase 2

Respiratory Syncytial Virus Infections

Dose 1 GSK2586881

Phase 2

Lung Injury, Acute

FF/Vilanterol (VI; GW642444M)

Phase 2

Asthma

GSK2982772 60 mg

Phase 2

Arthritis, Rheumatoid

GSK5460025

Phase 2

Neoplasms, Colorectal

SB480848 40mg EC Tablet

Phase 2

Atherosclerosis

RTS,S/AS01E (SB257049)

Phase 2

Malaria

GW856553

Phase 2

Arthritis, Rheumatoid

Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted

Phase 2

Influenza

Run In Medication

Phase 2

Nasal Polyps

Influenza Vaccine GSK1247446A

Phase 2

Influenza

tositumomab and iodine I-131 tositumomab

Phase 2

Lymphoma, Non-Hodgkin

Cervarix vaccine

Phase 2

Infections, Papillomavirus

GSK2269557 100 MCG

Phase 2

Pulmonary Disease, Chronic Obstructive

GSK2336805 40 mg

Phase 2

Hepatitis C, Chronic

pazopanib and pemetrexed

Phase 2

Lung Cancer, Non-Small Cell

GSK163090 1 mg

Phase 2

Depressive Disorder

Live attenuated rotavirus vaccine

Phase 2

Infections, Rotavirus

GSK2118436

Phase 2

Melanoma and Brain Metastases

Adjuvanted herpes simplex (gD) candidate vaccine GSK 208141

Phase 2

Prophylaxis Herpes Simplex

SB-480848

Phase 2

Atherosclerosis

GSK221149A

Phase 2

Obstetric Labour, Premature

letetresgene autoleucel (GSK3377794)

Phase 2

Neoplasms

SB497115

Phase 2

Purpura, Thrombocytopaenic, Idiopathic

GSK716155 subcutaneous injections

Phase 2

Diabetes Mellitus, Type 2

GSK4524101

Phase 2

Neoplasms

GSK Biologicals' HIV vaccine (732461)

Phase 2

AIDS

Docetaxel

Phase 2

Neoplasms

Influenza A (H5N1) Virus monovalent vaccine (GSK1557484A).

Phase 2

Influenza

Mepolizumab 750

Phase 2

Asthma

GW842166

Phase 2

Osteoarthritis, Knee

adjuvanted influenza vaccine

Phase 2

Influenza

Zalcitabine

Phase 2

HIV Infections

RSV vaccine GSK3003891A

Phase 2

Respiratory Syncytial Virus Infections

HPV 16/18 L1 AS04

Phase 2

Infections, Papillomavirus

vestipitant

Phase 2

Depressive Disorder and Anxiety Disorders

Human Rotavirus Vaccine - two different formulations

Phase 2

Infections, Rotavirus

rosiglitazone XR

Phase 2

Arthritis, Rheumatoid

Carbomer 980 (1146A)

Phase 2

Common Cold

pazopanib (GW786034)

Phase 2

Neoplasms, Uterine Cervix

GSK Biologicals' investigational TB vaccine (GSK692342)

Phase 2

Tuberculosis

RSVPreF3 OA investigational vaccine (GSK3844766A)

Phase 2

Respiratory Syncytial Virus Infections

Talnetant

Phase 2

Schizophrenia

retapamulin

Phase 2

Infections, Bacterial

GW642444

Phase 2

Pulmonary Disease, Chronic Obstructive

GSK4532990

Phase 2

Non-alcoholic Fatty Liver Disease

Fluticasone Propionate 100mcg via ACCUHALER/DISKUS

Phase 2

Asthma

Pneumococcal vaccine GSK2189242A

Phase 2

Infections, Streptococcal

Losmapimod tablets

Phase 2

Pulmonary Disease, Chronic Obstructive

Chloroquine 600mg

Phase 2

Malaria, Vivax

MenC-TT

Phase 2

Infections, Meningococcal

Bepirovirsen

Phase 2

Hepatitis B

Ranitidine hydrochloride

Phase 2

HIV Infections

GSK372475

Phase 2

Depressive Disorder

Flu mRNA (Formulation B1)

Phase 2

Influenza, Human

Tucaresol tablets 25 mg

Phase 2

HIV Infection

RSV MAT 60 µg

Phase 2

Respiratory Syncytial Virus Infections

FP 100

Phase 2

Asthma

oral nicotine

Phase 2

Smoking Dependence

Rotavirus

Phase 2

Infections, Rotavirus

DTPa-HBV-IPV/Hib (Infanrix-hexa™)

Phase 2

Hepatitis B

Lapatinib oral tablets

Phase 2

Neoplasms, Breast

nelarabine

Phase 2

Leukemia

GSK3228836

Phase 2

Hepatitis B

GSK2197870A

Phase 2

Neisseria Meningitidis

Lapatinib in combination with weekly paclitaxel

Phase 2

Neoplasms, Breast

GW685698X 200mcg,GW685698X 200mcg and 400mcg

Phase 2

Asthma

Losmapimod

Phase 2

Glomerulosclerosis, Focal Segmental

RTS,S/AS01E vaccine

Phase 2

Malaria

SB-773812

Phase 2

Schizophrenia

chlorambucil, tablets

Phase 2

Leukaemia, Lymphoblastic

Tositumomab and Iodine I 131 Tositumomab

Phase 2

Lymphoma, Non-Hodgkin

Nelfinavir mesylate

Phase 2

HIV Infections

SB705498 400 mg

Phase 2

Toothache

SB683699

Phase 2

Multiple Sclerosis, Relapsing-Remitting

683699

Phase 2

Crohn's Disease

GSK Biologicals' investigational vaccine GSK1562902A

Phase 2

Influenza

FFNS 110 mcg QD

Phase 2

Sinusitis, Acute

Topotecan/Docetaxel combination

Phase 2

Lung Cancer, Non-Small Cell

HPV9 High formulation

Phase 2

Cervical Intraepithelial Neoplasia

Pneumococcal vaccine GSK2189242A (formulation 1)

Phase 2

Infections, Streptococcal

Iodine I 131 Tositumomab Therapeutic Regimen

Phase 2

Lymphoma, Non-Hodgkin

Intravenous GR270773- Phospholipid Emulsion

Phase 2

Sepsis

Gemcitabine

Phase 2

Cancer

Unconjugated belantamab antibody

Phase 2

Multiple Myeloma

carboplatin

Phase 2

Primary Peritoneal Carcinoma

GSK2110183

Phase 2

Langerhans Cell Histiocytosis

Dose 4 QD

Phase 2

Asthma

Stavudine

Phase 2

HIV Infections

Prophylaxis: Diphtheria, tetanus, pertussis, poliovirus type 1, type 2 and type 3

Phase 2

Diphtheria

Herpes Zoster vaccine GSK1437173A Low Dose

Phase 2

Herpes Zoster

SRA737, gemcitabine, cisplatin

Phase 2

Advanced Solid Tumors

Firategrast 150 mg

Phase 2

Multiple Sclerosis

vinorelbine tartrate

Phase 2

Lung Cancer

NC-758 (Anti amyloidotic [Aß] agent)

Phase 2

Stroke

GSK2340274A

Phase 2

Influenza

Batefenterol

Phase 2

Pulmonary Disease, Chronic Obstructive

GSK Biologicals' influenza vaccine GSK1557482A

Phase 2

Influenza

Ritonavir

Phase 2

HIV Infections

SB-705498

Phase 2

Rhinitis

Fluticasone Furoate (FF)

Phase 2

Asthma

GSK573179

Phase 2

Pulmonary Disease, Chronic Obstructive

GW823093 15mg

Phase 2

Diabetes Mellitus, Type 2

Talarozole

Phase 2

Psoriasis

cycolophosphamide, vacristine, and pednisone (CVP) x6 cycles followed by tositumomab and iodine I 131 tositumomab.

Phase 2

Lymphoma, Non-Hodgkin

Non-adjuvanted HSV formulation 1

Phase 2

Herpes Simplex

Ambrisentan

Phase 2

Hypertension, Pulmonary

SB-742457

Phase 2

Alzheimer's Disease

GSK2245035

Phase 2

Asthma and Rhinitis

PNT2258

Phase 2

Lymphoma, Non-Hodgkin's

Rotavirus (vaccine)

Phase 2

Rotavirus Infections

GSK2330672

Phase 2

Cholestasis, Intrahepatic

GW870086X

Phase 2

Asthma

risperidone

Phase 2

Schizophrenia

Efavirenz

Phase 2

HIV Infections

Radafaxine

Phase 2

Major Depressive Disorder (MDD)

IONIS-HBVRx

Phase 2

Hepatitis B

GSK Biologicals' investigational TB vaccine GSK 692342

Phase 2

Tuberculosis

RTS,S/AS02A

Phase 2

Malaria

Mapatumumab

Phase 2

Carcinoma, Hepatocellular

SERETIDE Rotacaps

Phase 2

Asthma

GSK256066

Phase 2

Asthma

GSK's investigational vaccine 692342

Phase 2

Tuberculosis

0.12% chlorhexidine mouthrinse

Phase 2

Healthy Subjects

GSK2881078

Phase 2

Cachexia

Albaconazole 100mg

Phase 2

Onychomycosis

Tositumomab 450 mg

Phase 2

Lymphoma, Non-Hodgkin

GSK962040 (5 mg tablet)

Phase 2

Gastroparesis

100 micrograms Fluticasone propionate

Phase 2

Asthma

HRV vaccine

Phase 2

Infections, Rotavirus

GW501516 oral tablets

Phase 2

Dyslipidaemias

Pandemic influenza vaccine GSK2340272A

Phase 2

Influenza

GSK Biologicals' Candidate Tuberculosis (TB) Vaccine (692342)

Phase 2

Tuberculosis (TB)

Meningococcal (vaccine)

Phase 2

Infections, Meningococcal

Benzoyl peroxide gel

Phase 2

Acne Vulgaris

CV0701 mRNA COVID-19 Vaccine (Low dose)

Phase 2

SARS-CoV-2

GW679769

Phase 2

Depressive Disorder, Major

MMB

Phase 2

Primary Myelofibrosis (PMF)

Flu Pandemic mRNA_Dose level 1

Phase 2

Influenza, Human

Zanamivir

Phase 2

Influenza, Human

NC-503 (eprodisate disodium)

Phase 2

Diabetes Mellitus, Type 2

GSK1363089 (foretinib)

Phase 2

Neoplasms, Head and Neck

Nanomilled testosterone

Phase 2

Hypogonadism

GW677954

Phase 2

Metabolic Syndrome X

SRT2104

Phase 2

Diabetes Mellitus, Type 2

UMEC

Phase 2

Asthma

Candidate Influenza Vaccine GSK1247446A - 2 different formulations

Phase 2

Influenza

GW786034

Phase 2

Carcinoma, Renal Cell

GW685698/GW642444

Phase 2

Pulmonary Disease, Chronic Obstructive

topotecan

Phase 2

Lung Cancer, Small Cell

SRA737

Phase 2

Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)

GSK962040 25 mg

Phase 2

Gastroparesis

GSK189075

Phase 2

Diabetes Mellitus, Type 2

NTHi Mcat investigational vaccine (GSK3277511A)

Phase 2

Respiratory Disorders

CYT387

Phase 2

Primary Myelofibrosis

GSK3196165

Phase 2

Arthritis, Rheumatoid

GSK249320

Phase 2

Ischaemic Attack, Transient

eltrombopag

Phase 2

Purpura, Thrombocytopaenic, Idiopathic

HPV 16/18 VLP AS04

Phase 2

Infections, Papillomavirus

fluticasone propionate/salmeterol

Phase 2

Asthma

GW274150

Phase 2

Migraine Disorders

SB681323

Phase 2

Pain, Neuropathic

Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply